Pfizer reportedly seeking OK for fourth COVID dose for seniors

WASHINGTON (AP) — Drugmaker Pfizer is expected to request authorisation this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter.

It would add a fourth dose to the regimen — currently a primary series of two shots, followed months later by a booster dose — in an effort to provide maximum protection to the over-65 population that has been hit hardest by the pandemic.

The Food and Drug Administration and the Centers for Disease Control would have to approve the request.

The person who spoke about the upcoming Pfizer authorisation request spoke on condition of anonymity because the person wasn't authorised to speak on the record.

“We're continuing to collect and assess all available data and we're in continuous, open dialogue with regulators and health authorities to help inform a COVID-19 vaccine strategy as the virus evolves,” said Pfizer spokeswoman Jerica Pitts.

Speaking to CBS' “Face the Nation” on Sunday, Pfizer CEO Albert Bourla said, “Right now, the way that we have seen, it is necessary, a fourth booster right now. The protection that you are getting from the third, it is good enough, actually quite good for hospitalizations and deaths. It's not that good against infections but doesn't last very long. But we are just submitting those data to the FDA and then we will see what the experts also will say outside Pfizer.”

With COVID-19 cases finally plummeting after the intense omicron surge, public health experts are starting to look ahead to what next steps might be needed — if a new variant crops up or, barring that, whether to try shoring up coronavirus protection in the fall at the same time people get flu vaccinations.

The US booster campaign was based on evidence that the shots' effectiveness, especially against milder infections, was waning about six months after the last dose.

Calls for a third shot grew once it became clear the vaccines weren't as strong against the omicron mutant as they were against earlier versions of the virus.

Many scientists say the ultimate goal of vaccination is to prevent severe illness, and early CDC data show the shots still are doing that.

During the omicron wave, effectiveness against hospitalisation was 91% in people who had gotten their booster two months earlier, and 78% by the fourth month after that booster.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.